Top ▲
GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Unless otherwise stated all data on this page refer to the human proteins. Gene information is provided for human (Hs), mouse (Mm) and rat (Rn).
Mitochondrial nucleotide transporters, defined by structural similarlities, include the adenine nucleotide translocator family (SLC25A4, SLC25A5, SLC25A6 and SLC25A31), which under conditions of aerobic metabolism, allow coupling between mitochondrial oxidative phosphorylation and cytosolic energy consumption by exchanging cytosolic ADP for mitochondrial ATP. Further members of the mitochondrial nucleotide transporter subfamily convey diverse substrates including CoA, although not all members have had substrates identified.
ANT1 (Mitochondrial adenine nucleotide translocator 1 / SLC25A4) C Show summary »« Hide summary
|
||||||||||||||||||||||||||||
ANT2 (Mitochondrial adenine nucleotide translocator 2 / SLC25A5) C Show summary »« Hide summary
|
||||||||||||||||||||||||||||
ANT3 (Mitochondrial adenine nucleotide translocator 3 / SLC25A6) C Show summary »« Hide summary
|
||||||||||||||||||||||||||||
ANT4 (Mitochondrial adenine nucleotide translocator 4 / SLC25A31) C Show summary »« Hide summary
|
||||||||||||||||||||||||||||
GDC (Graves disease carrier / SLC25A16) C Show summary »« Hide summary
|
||||||||||||||||||||||||||||
PMP34 (Peroxisomal membrane protein / SLC25A17) C Show summary »« Hide summary
|
||||||||||||||||||||||||||||
APC1 (Mitochondrial ATP-Mg/phosphate carrier 1 / SLC25A24) C Show summary »« Hide summary
|
||||||||||||||||||||||||||||
APC2 (Mitochondrial ATP-Mg/phosphate carrier 2 / SLC25A23) C Show summary »« Hide summary
|
||||||||||||||||||||||||||||
APC3 (Mitochondrial ATP-Mg/phosphate carrier 3 / SLC25A25) C Show summary »« Hide summary
|
||||||||||||||||||||||||||||
APC4 (Mitochondrial ATP-Mg/phosphate carrier 4 / SLC25A41) C Show summary »« Hide summary
|
||||||||||||||||||||||||||||
PNC1 (Mitochondrial pyrimidine nucleotide transporter 1 / SLC25A33) C Show summary »« Hide summary
|
||||||||||||||||||||||||||||
PNC2 (Mitochondrial pyrimidine nucleotide transporter 2 / SLC25A36) C Show summary »« Hide summary
|
||||||||||||||||||||||||||||
SLC25A43 Show summary »« Hide summary
|
* Key recommended reading is highlighted with an asterisk
* Cozens AL, Runswick MJ, Walker JE. (1989) DNA sequences of two expressed nuclear genes for human mitochondrial ADP/ATP translocase. J Mol Biol, 206 (2): 261-80. [PMID:2541251]
* del Arco A, Satrústegui J. (2004) Identification of a novel human subfamily of mitochondrial carriers with calcium-binding domains. J Biol Chem, 279 (23): 24701-13. [PMID:15054102]
* Di Noia MA, Todisco S, Cirigliano A, Rinaldi T, Agrimi G, Iacobazzi V, Palmieri F. (2014) The human SLC25A33 and SLC25A36 genes of solute carrier family 25 encode two mitochondrial pyrimidine nucleotide transporters. J Biol Chem, 289 (48): 33137-48. [PMID:25320081]
* Dolce V, Scarcia P, Iacopetta D, Palmieri F. (2005) A fourth ADP/ATP carrier isoform in man: identification, bacterial expression, functional characterization and tissue distribution. FEBS Lett, 579 (3): 633-7. [PMID:15670820]
* Mifsud J, Ravaud S, Krammer EM, Chipot C, Kunji ER, Pebay-Peyroula E, Dehez F. (2013) The substrate specificity of the human ADP/ATP carrier AAC1. Mol Membr Biol, 30 (2): 160-8. [PMID:23173940]
* Monné M, Daddabbo L, Giannossa LC, Nicolardi MC, Palmieri L, Miniero DV, Mangone A, Palmieri F. (2017) Mitochondrial ATP-Mg/phosphate carriers transport divalent inorganic cations in complex with ATP. J Bioenerg Biomembr, 49 (5): 369-380. [PMID:28695448]
* Ruprecht JJ, Kunji ER. (2019) Structural changes in the transport cycle of the mitochondrial ADP/ATP carrier. Curr Opin Struct Biol, 57: 135-144. [PMID:31039524]
* Ruprecht JJ, Kunji ERS. (2021) Structural Mechanism of Transport of Mitochondrial Carriers. Annu Rev Biochem, 90: 535-558. [PMID:33556281]
* Traba J, Satrústegui J, del Arco A. (2009) Characterization of SCaMC-3-like/slc25a41, a novel calcium-independent mitochondrial ATP-Mg/Pi carrier. Biochem J, 418 (1): 125-33. [PMID:18928449]
1. Jaiquel Baron S, King MS, Kunji ERS, Schirris TJJ. (2021) Characterization of drug-induced human mitochondrial ADP/ATP carrier inhibition. Theranostics, 11 (11): 5077-5091. [PMID:33859735]
2. Ruprecht JJ, Hellawell AM, Harding M, Crichton PG, McCoy AJ, Kunji ER. (2014) Structures of yeast mitochondrial ADP/ATP carriers support a domain-based alternating-access transport mechanism. Proc Natl Acad Sci U S A, 111 (4): E426-34. [PMID:24474793]
3. Ruprecht JJ, King MS, Zögg T, Aleksandrova AA, Pardon E, Crichton PG, Steyaert J, Kunji ERS. (2019) The Molecular Mechanism of Transport by the Mitochondrial ADP/ATP Carrier. Cell, 176 (3): 435-447.e15. [PMID:30611538]
Database page citation:
Mitochondrial nucleotide transporter subfamily. Accessed on 12/09/2025. IUPHAR/BPS Guide to PHARMACOLOGY, http://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=206.
Concise Guide to PHARMACOLOGY citation:
Alexander SPH, Fabbro D, Kelly E, Mathie AA, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Davies JA et al. (2023) The Concise Guide to PHARMACOLOGY 2023/24: Transporters. Br J Pharmacol. 180 Suppl 2:S374-469.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License